InsiderFlow

LXRX

Lexicon Pharmaceuticals, Inc.$1.67-0.03 (-1.48%)
Prev Close$1.69·MCap$711.8M·P/E·Vol840.2K·Yield

Buys (12M)

7

$3.12M

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$3.12M

Active Insiders

2

last 12 mo

Over the past 12 months, insider activity at Lexicon Pharmaceuticals, Inc. (LXRX) has been exclusively buying, with 7 insider purchases totaling $3.12M and 0 insider sales totaling $0.00. The most recent insider transaction was by DEBBANE RAYMOND (director), who purchased $3.0K worth of shares on Feb 27, 2026. Lexicon Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $711.8M.

LXRX Insider Trading Activity

DateInsiderTypeValue
Feb 27, 2026 DEBBANE RAYMONDBuy$3.0K
Feb 25, 2026 DEBBANE RAYMONDBuy$147.0K
Feb 23, 2026 DEBBANE RAYMONDBuy$219.8K
Feb 19, 2026 DEBBANE RAYMONDBuy$219.8K
Feb 18, 2026 DEBBANE RAYMONDBuy$176.4K
Feb 13, 2026 DEBBANE RAYMONDBuy$352.9K
Feb 4, 2026 Invus Global Management, LLCBuy$2.00M
Nov 17, 2023 COATS LONNELBuy$94.8K
Nov 14, 2023 Amouyal PhilippeBuy$201.5K
Nov 13, 2023 COATS LONNELBuy$10.1K
Oct 12, 2023 DEBBANE RAYMONDBuy$1.10M
Sep 14, 2023 WADE JEFFREY LBuy$13.8K
Aug 7, 2023 McDermott WendyBuy$11.0K
Jun 29, 2023 COATS LONNELBuy$21.6K
Jun 27, 2023 McDermott WendyBuy$24.3K
Jun 26, 2023 COATS LONNELBuy$46.7K
Jun 22, 2023 COATS LONNELBuy$92.4K
Jun 20, 2023 WADE JEFFREY LBuy$28.0K
Jun 5, 2023 Artal International S.C.A.Buy$72.22M6.6% OS
Aug 9, 2022 Artal International S.C.A.Buy$6.07M0.6% OS
Aug 9, 2022 Invus US Partners LLCBuy$368.5K
Aug 1, 2022 Artal International S.C.A.Buy$40.43M3.8% OS
Aug 1, 2022 Invus US Partners LLCBuy$2.46M
Mar 16, 2021 Tessmer James FSell$158.4K

LXRX Insider Buying Activity

The following table shows recent insider purchases of Lexicon Pharmaceuticals, Inc. (LXRX) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Feb 27, 2026 DEBBANE RAYMONDBuy$3.0K
Feb 25, 2026 DEBBANE RAYMONDBuy$147.0K
Feb 23, 2026 DEBBANE RAYMONDBuy$219.8K
Feb 19, 2026 DEBBANE RAYMONDBuy$219.8K
Feb 18, 2026 DEBBANE RAYMONDBuy$176.4K
Feb 13, 2026 DEBBANE RAYMONDBuy$352.9K
Feb 4, 2026 Invus Global Management, LLCBuy$2.00M
Nov 17, 2023 COATS LONNELBuy$94.8K
Nov 14, 2023 Amouyal PhilippeBuy$201.5K
Nov 13, 2023 COATS LONNELBuy$10.1K
Oct 12, 2023 DEBBANE RAYMONDBuy$1.10M
Sep 14, 2023 WADE JEFFREY LBuy$13.8K
Aug 7, 2023 McDermott WendyBuy$11.0K
Jun 29, 2023 COATS LONNELBuy$21.6K
Jun 27, 2023 McDermott WendyBuy$24.3K
Jun 26, 2023 COATS LONNELBuy$46.7K
Jun 22, 2023 COATS LONNELBuy$92.4K
Jun 20, 2023 WADE JEFFREY LBuy$28.0K
Jun 5, 2023 Artal International S.C.A.Buy$72.22M6.6% OS
Aug 9, 2022 Artal International S.C.A.Buy$6.07M0.6% OS
Aug 9, 2022 Invus US Partners LLCBuy$368.5K
Aug 1, 2022 Artal International S.C.A.Buy$40.43M3.8% OS
Aug 1, 2022 Invus US Partners LLCBuy$2.46M

LXRX Insider Selling Activity

The following table shows recent insider sales of Lexicon Pharmaceuticals, Inc. (LXRX) stock reported via SEC Form 4 filings.

DateInsiderTypeValue
Mar 16, 2021 Tessmer James FSell$158.4K

LXRX Insiders

DEBBANE RAYMOND

Director

Bought $2.22M
7 tradesLast: Feb 27, 2026
Invus Global Management, LLC

director, 10 percent owner:

Bought $2.00M
1 tradesLast: Feb 4, 2026
COATS LONNEL

Chief Executive Officer

Bought $265.6K
5 tradesLast: Nov 17, 2023
Amouyal Philippe

Director

Bought $201.5K
1 tradesLast: Nov 14, 2023
WADE JEFFREY L

President and CFO

Bought $41.8K
2 tradesLast: Sep 14, 2023
McDermott Wendy

VP, Human Resources

Bought $35.3K
2 tradesLast: Aug 7, 2023
Artal International S.C.A.

Director

Bought $118.71M
3 tradesLast: Jun 5, 2023
Invus US Partners LLC

Director

Bought $2.82M
2 tradesLast: Aug 9, 2022
Tessmer James F

VP, Finance & Accounting

Sold $158.4K
1 tradesLast: Mar 16, 2021